Effectiveness and toxicity of adjuvant chemotherapy in patients with non-small cell lung cancer.
Guilherme HaradaMaria Fernanda Batistuzzo Vicentini NeffaRenata Colombo BonadioElizabeth Zambrano MendozaRafael CaparicaLetícia Leone LauricellaTeresa Yae TakagakiFelipe Santa Rosa RoitbergRicardo Mingarini TerraGilberto de Castro JuniorPublished in: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia (2021)
These results support the benefit of AC for NSCLC patients in a real-world setting. However, because the cisplatin-vinorelbine regimen was associated with alarming rates of toxicity, more effective and less toxic alternatives should be investigated.
Keyphrases
- end stage renal disease
- newly diagnosed
- small cell lung cancer
- oxidative stress
- chronic kidney disease
- randomized controlled trial
- systematic review
- peritoneal dialysis
- advanced non small cell lung cancer
- radiation therapy
- patient reported outcomes
- phase ii study
- atomic force microscopy
- epidermal growth factor receptor